- Conditions
- Newly Diagnosed MGMT Unmethylated Glioblastoma
- Interventions
- D2C7-IT, 2141-V11
- Drug
- Lead sponsor
- Darell Bigner
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
Source: ClinicalTrials.gov public record
Updated Oct 5, 2025 · Synced May 21, 2026, 7:24 PM EDT